CVE-2024-28231

CVE-2024-28231 is a critical-severity vulnerability in Eprosima Fast Dds with a CVSS 3.x base score of 9.6. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-787.

Key facts

Description

eprosima Fast DDS is a C++ implementation of the Data Distribution Service standard of the Object Management Group. Prior to versions 2.14.0, 2.13.4, 2.12.3, 2.10.4, and 2.6.8, manipulated DATA Submessage can cause a heap overflow error in the Fast-DDS process, causing the process to be terminated remotely. Additionally, the payload_size in the DATA Submessage packet is declared as uint32_t. When a negative number, such as -1, is input into this variable, it results in an Integer Overflow (for example, -1 gets converted to 0xFFFFFFFF). This eventually leads to a heap-buffer-overflow, causing the program to terminate. Versions 2.14.0, 2.13.4, 2.12.3, 2.10.4, and 2.6.8 contain a fix for this issue.

Frequently asked questions

What is CVE-2024-28231?
eprosima Fast DDS is a C++ implementation of the Data Distribution Service standard of the Object Management Group. Prior to versions 2.14.0, 2.13.4, 2.12.3, 2.10.4, and 2.6.8, manipulated DATA Submessage can cause a heap overflow error in the Fast-DDS process, causing the process to be terminated remotely. Additionally, the payload_size in the DATA Submessage packet is declared as uint32_t. When a negative number, such as -1, is input into this variable, it results in an Integer Overflow (for example, -1 gets converted to 0xFFFFFFFF). This eventually leads to a heap-buffer-overflow, causing the program to terminate. Versions 2.14.0, 2.13.4, 2.12.3, 2.10.4, and 2.6.8 contain a fix for this issue.
How severe is CVE-2024-28231?
CVE-2024-28231 has a CVSS 3.x base score of 9.6, rated critical severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2024-28231 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (57th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-28231?
CVE-2024-28231 affects Eprosima Fast Dds. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-28231?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
Does CVE-2024-28231 have an EU (EUVD) identifier?
Yes. CVE-2024-28231 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-25347.
When was CVE-2024-28231 published?
CVE-2024-28231 was published on 2024-03-20 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Eprosima Fast Dds

All CVEs affecting Eprosima Fast Dds →

Other CWE-787 (Out-of-bounds Write) vulnerabilities

Browse all CWE-787 (Out-of-bounds Write) vulnerabilities →